CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.650
-0.140 (-5.02%)
Dec 20, 2024, 4:00 PM EST - Market closed
CASI Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | -26.94 | -41.01 | -36.65 | -48.29 | -46.03 | Upgrade
|
| Depreciation & Amortization | - | 3.74 | 2.42 | 1.82 | 1.96 | 2.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 2.06 | 0.07 | -1.15 | 0.41 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 8.72 | 6.56 | 19.37 | 7.35 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 2.59 | 3.57 | -4.8 | -4.32 | 0.29 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.05 | 0.85 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 7.22 | 7.01 | 7.77 | 7.82 | 7.31 | Upgrade
|
| Other Operating Activities | - | 1.19 | 1.95 | 1.62 | 2.05 | 1.25 | Upgrade
|
| Change in Accounts Receivable | - | 3.42 | -3.17 | -5.16 | -3.35 | -1.29 | Upgrade
|
| Change in Inventory | - | -9.74 | -4.23 | -0.55 | 3.19 | -4.41 | Upgrade
|
| Change in Accounts Payable | - | 1.15 | 1.07 | 1.49 | -1.54 | 4 | Upgrade
|
| Change in Income Taxes | - | -1.89 | 1.98 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | - | -0.76 | -2.3 | 1 | -1.61 | 5.73 | Upgrade
|
| Operating Cash Flow | - | -19.97 | -21.09 | -26.84 | -25.89 | -23.24 | Upgrade
|
| Capital Expenditures | - | -0.2 | -5.61 | -8.95 | -1.5 | -0.43 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.14 | 0.01 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -2.04 | - | -6.56 | -15.13 | -13.59 | Upgrade
|
| Investment in Securities | - | -8.43 | 30.2 | - | -6.32 | -14.04 | Upgrade
|
| Other Investing Activities | - | - | 6.44 | 0.47 | 2.31 | - | Upgrade
|
| Investing Cash Flow | - | -9.67 | 31.16 | -20.69 | -20.72 | -28.06 | Upgrade
|
| Short-Term Debt Issued | - | - | 4 | 0.71 | 1.25 | - | Upgrade
|
| Total Debt Issued | - | - | 4 | 0.71 | 1.25 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -4 | -1.55 | - | -1.5 | Upgrade
|
| Total Debt Repaid | - | - | -4 | -1.55 | - | -1.5 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.84 | 1.25 | -1.5 | Upgrade
|
| Issuance of Common Stock | - | 0.11 | - | 32.5 | 48.97 | 4.31 | Upgrade
|
| Repurchase of Common Stock | - | -0.28 | -3.27 | - | -0.25 | -0.37 | Upgrade
|
| Common Dividends Paid | - | -0.74 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -2.02 | -2.82 | 19.6 | Upgrade
|
| Financing Cash Flow | - | -0.91 | -3.27 | 29.64 | 47.15 | 22.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.52 | 1.6 | -0.47 | 2.9 | -1.33 | Upgrade
|
| Net Cash Flow | - | -30.03 | 8.41 | -18.36 | 3.44 | -30.58 | Upgrade
|
| Free Cash Flow | - | -20.17 | -26.7 | -35.79 | -27.39 | -23.67 | Upgrade
|
| Free Cash Flow Margin | - | -59.54% | -61.94% | -118.63% | -180.87% | -572.98% | Upgrade
|
| Free Cash Flow Per Share | - | -1.51 | -1.96 | -2.63 | -2.48 | -2.47 | Upgrade
|
| Cash Interest Paid | - | - | 0.06 | 0.04 | - | 0.03 | Upgrade
|
| Cash Income Tax Paid | - | 1.81 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | -13.71 | -17.41 | -27.29 | -25.87 | -27.93 | Upgrade
|
| Unlevered Free Cash Flow | - | -13.71 | -17.41 | -27.29 | -25.86 | -27.93 | Upgrade
|
| Change in Net Working Capital | 0.91 | 6.63 | 4.68 | -0.63 | -1.8 | -1.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.